Specifications TableSubjectChemistrySpecific subject areaOrganic chemistry\
Analytical chemistryType of dataTable\
FigureHow data were acquiredAgilent 1100 series and 1260 infinity system\
Bruker ultrashield™ NMR spectrometer 600 MHz\
Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS spectrometerData formatRaw (as supplementary file)\
AnalyzedParameters for data collectionThe purified compounds were subjected to HPLC and qNMR analysis. The mobile phase for HPLC analysis were acetonitrile and water. The ratio was specified in the "Experimental Design, Materials, and Methods" section. The flow rate was set as 1.000 mL/min. Compounds were dissolved in *d*-DMSO prior to qNMR analysis. The parameters for qNMR analysis were adjusted according to the literature \[[@bib5]\].Description of data collectionHPLC profiles of 95 novel compounds were recorded on and exported from an Agilent 1100 series and 1260 infinity system. Area% and RetTime stands for purity and retention time, respectively. qNMR spectra data of 95 novel compounds were recorded on and exported form a Bruker ultrashield™ NMR spectroscope 600 MHz spectrometer using standard Bruker pulse programs. Chemical shifts were shown as δ-values.\
Positive- and negative-ion HRESI-TOF-MS of 95 novel compounds were recorded on and exported from an Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS spectrometer.Data source locationDepartment of Applied Biology and Chemical Technology, the Hong Kong Polytechnic University, Hong Kong SARData accessibilityData are available with the article**Value of the Data**•Nusbiarylins are the first-in-class bacterial ribosomal RNA synthesis inhibitors that possess potent activity against various types of multidrug-resistant bacteria with a novel mode of action•Spectral data of nusbiarylins are useful for elucidating their purity•The HPLC profiles, qNMR and HRMS spectroscopic data are of 95 unreported compounds and could be useful for the characterization by other researchers

1. Data {#sec1}
=======

Bacterial transcription is a valid but underutilized target for antimicrobial agent discovery \[[@bib1]\]. NusB and NusE are bacteria-specific transcription factors essential for cell viability \[[@bib1],[@bib2]\]. Inhibitors of the NusB-NusE interaction were discovered and named nusbiarylins. The name was derived from the target protein NusB and their biaryl structure \[[@bib2], [@bib3], [@bib4]\]. The dataset contains high-performance liquid chromatography (HPLC) profiles of 90 compounds, quantitative nuclear magnetic resonance (qNMR) spectroscopic data of 5 compounds and high-resolution mass spectrometry (HRMS) profiles of all 95 compounds \[[@bib3],[@bib4]\]. The data file (HPLC, qNMR and HRMS spectra) is available publicly within this data article as a supplementary file. The compound structures were presented in [Table 1](#tbl1){ref-type="table"}, purities in [Table 2](#tbl2){ref-type="table"} and HRMS data in [Table 3](#tbl3){ref-type="table"}. The testing methods and parameters of different compounds by HPLC, HRMS and qNMR were also described.Table 1Chemical structures of 95 nusbiarylin compounds as NusB-NusE inhibitors.Table 1Table 2Data on purities by HPLC or qNMR and retention time (HPLC) of nusbiarylin compounds.Table 2CompoundPurity/%Retention time/min**1**99.96.51**2**99.011.23**3**99.89.06**4**98.29.35**5**98.09.47**6**100.09.32**7**99.59.90**8**99.810.12**9**99.910.12**10**99.412.10**11**100.012.35**12**99.212.50**13**96.05.66**14**97.86.59**15**96.16.35**16**98.510.17**17**96.610.51**18**95.510.50**19**97.87.80**20**98.79.04**21**99.99.02**22**98.4qNMR**23**97.29.15**24**98.9qNMR**25**100.010.09**26**98.310.55**27**97.3qNMR**28**97.48.98**29**97.09.76**30**95.59.69**31**95.35.95**32**97.25.77**33**91.0qNMR**34**99.29.21**35**100.07.86**36**99.46.48**37**99.76.81**38**97.76.70**39**99.86.58**40**99.87.14**41**100.07.11**42**98.07.17**43**99.48.67**44**98.68.92**45**99.69.15**46**96.35.25**47**99.34.70**48**99.57.45**49**99.37.35**50**99.77.32**51**98.96.82**52**99.76.27**53**97.66.05**54**99.67.44**55**98.06.21**56**99.65.80**57**99.47.84**58**99.07.72**59**97.67.68**60**98.76.79**61**99.44.33**62**98.912.92**63**98.19.85**64**97.19.87**65**99.49.02**66**97.78.46**67**97.69.46**68**99.89.68**69**99.99.32**70**99.89.62**71**97.29.73**72**98.08.46**73**95.17.03**74**97.7qNMR**75**99.412.08**76**98.36.52**77**99.26.98**78**99.16.33**79**99.76.19**80**98.76.54**81**99.66.94**82**99.48.25**83**99.98.43**84**99.67.23**85**99.58.45**86**99.77.93**87**100.08.96**88**95.58.02**89**97.28.05**90**97.47.91**91**96.87.20**92**97.67.79**93**97.77.76**94**98.917.74**95**99.77.46Table 3HRMS data of nusbiarylin compounds.Table 3CompoundIon formulam/z (calculated)m/z (found)**1**C~13~H~15~N~2~O~3~ \[M − H\]^-^247.1088247.1089**2**C~17~H~11~N~2~O~3~ \[M − H\]^-^291.0775291.0773**3**C~13~H~9~N~2~O~3~ \[M − H\]^-^241.0619241.0620**4**C~13~H~8~FN~2~O~3~ \[M − H\]^-^259.0524259.0523**5**C~13~H~8~FN~2~O~3~ \[M − H\]^-^259.0524259.0528**6**C~13~H~8~FN~2~O~3~ \[M − H\]^-^259.0524259.0522**7**C~14~H~11~N~2~O~3~ \[M − H\]^-^255.0775255.0771**8**C~14~H~11~N~2~O~3~ \[M − H\]^-^255.0775255.0772**9**C~14~H~11~N~2~O~3~ \[M − H\]^-^255.0775255.0772**10**C~17~H~17~N~2~O~3~ \[M − H\]^-^297.1245297.1247**11**C~17~H~17~N~2~O~3~ \[M − H\]^-^297.1245297.1242**12**C~17~H~17~N~2~O~3~ \[M − H\]^-^297.1245297.1243**13**C~13~H~9~N~2~O~4~ \[M − H\]^-^257.0568257.0565**14**C~13~H~9~N~2~O~4~ \[M − H\]^-^257.0568257.0568**15**C~13~H~9~N~2~O~4~ \[M − H\]^-^257.0568257.0567**16**C~13~H~8~ClN~2~O~3~ \[M − H\]^-^275.0229275.0227**17**C~13~H~8~ClN~2~O~3~ \[M − H\]^-^275.0229275.0226**18**C~13~H~8~ClN~2~O~3~ \[M − H\]^-^275.0229275.0226**19**C~14~H~11~N~2~O~4~ \[M − H\]^-^271.0724271.0719**20**C~14~H~11~N~2~O~4~ \[M − H\]^-^271.0724271.0721**21**C~14~H~11~N~2~O~4~ \[M − H\]^-^271.0724271.0727**22**C~15~H~11~N~2~O~5~ \[M − H\]^-^299.0673299.0672**23**C~15~H~11~N~2~O~5~ \[M − H\]^-^299.0673299.0669**24**C~15~H~11~N~2~O~5~ \[M − H\]^-^299.0673299.0672**25**C~14~H~8~F~3~N~2~O~3~ \[M − H\]^-^309.0493309.0492**26**C~14~H~8~F~3~N~2~O~3~ \[M − H\]^-^309.0493309.0491**27**C~14~H~8~F~3~N~2~O~3~ \[M − H\]^-^309.0493309.0490**28**C~15~H~9~N~2~O~3~ \[M − H\]^-^265.0619265.0618**29**C~15~H~9~N~2~O~3~ \[M − H\]^-^265.0619265.0620**30**C~15~H~9~N~2~O~3~ \[M − H\]^-^265.0619265.0615**31**C~14~H~11~N~2~O~4~ \[M − H\]^-^271.0724271.0721**32**C~14~H~11~N~2~O~4~ \[M − H\]^-^271.0724271.0722**33**C~14~H~9~N~2~O~5~ \[M − H\]^-^285.0517285.0513**34**C~13~H~17~N~2~O~3~ \[M − H\]^-^249.1245249.1245**35**C~17~H~13~N~2~O~3~ \[M − H\]^-^293.0932293.0929**36**C~13~H~11~N~2~O~3~ \[M − H\]^-^243.0775243.0775**37**C~13~H~10~FN~2~O~3~ \[M − H\]^-^261.0681261.0683**38**C~13~H~10~FN~2~O~3~ \[M − H\]^-^261.0681261.0679**39**C~13~H~10~FN~2~O~3~ \[M − H\]^-^261.0681261.0682**40**C~14~H~13~N~2~O~3~ \[M − H\]^-^257.0932257.0928**41**C~14~H~13~N~2~O~3~ \[M − H\]^-^257.0932257.0928**42**C~14~H~13~N~2~O~3~ \[M − H\]^-^257.0932257.0927**43**C~17~H~19~N~2~O~3~ \[M − H\]^-^299.1401299.1401**44**C~17~H~19~N~2~O~3~ \[M − H\]^-^299.1401299.1399**45**C~17~H~19~N~2~O~3~ \[M − H\]^-^299.1401299.1404**46**C~13~H~11~N~2~O~4~ \[M − H\]^-^259.0724259.0723**47**C~13~H~11~N~2~O~4~ \[M − H\]^-^259.0724259.0723**48**C~13~H~10~ClN~2~O~3~ \[M − H\]^-^277.0385277.0384**49**C~13~H~10~ClN~2~O~3~ \[M − H\]^-^277.0385277.0387**50**C~13~H~10~ClN~2~O~3~ \[M − H\]^-^277.0385277.0386**51**C~14~H~13~N~2~O~4~ \[M − H\]^-^273.0881273.0878**52**C~14~H~13~N~2~O~4~ \[M − H\]^-^273.0881273.0876**53**C~14~H~13~N~2~O~4~ \[M − H\]^-^273.0881273.0881**54**C~15~H~13~N~2~O~5~ \[M − H\]^-^301.0830301.0833**55**C~15~H~13~N~2~O~5~ \[M − H\]^-^301.0830301.0831**56**C~15~H~13~N~2~O~5~ \[M − H\]^-^301.0830301.0826**57**C~14~H~10~F~3~N~2~O~3~ \[M − H\]^-^311.0649311.0651**58**C~14~H~10~F~3~N~2~O~3~ \[M − H\]^-^311.0649311.0650**59**C~14~H~10~F~3~N~2~O~3~ \[M − H\]^-^311.0649311.0654**60**C~15~H~11~N~2~O~3~ \[M − H\]^-^267.0775267.0773**61**C~14~H~13~N~2~O~4~ \[M − H\]^-^273.0881273.0879**62**C~14~H~11~N~2~O~5~ \[M − H\]^-^287.0673287.0673**63**C~17~H~12~NO~3~ \[M − H\]^-^278.0823278.0822**64**C~15~H~9~FNO \[M − H\]^-^238.0674238.0672**65**C~16~H~9~N~2~O \[M − H\]^-^245.0720245.0719**66**C~17~H~11~N~2~O \[M − H\]^-^259.0877259.0876**67**C~16~H~12~NO~2~ \[M − H\]^-^258.0874258.0875**68**C~15~H~10~NO \[M − H\]^-^220.0768220.0772**69**C~15~H~11~N~2~O~2~ \[M + H\]^+^251.0815251.0818**70**C~16~H~13~N~2~O~3~ \[M + H\]^+^281.0921281.0922**71**C~15~H~9~N~2~O~3~ \[M − H\]^-^265.0619265.0620**72**C~15~H~9~N~2~O~3~ \[M − H\]^-^265.0619265.0616**73**C~15~H~9~N~2~O~3~ \[M − H\]^-^265.0619265.0621**74**C~15~H~8~BrN~2~O~3~ \[M − H\]^-^342.9724342.9727**75**C~15~H~8~C~l2~NO \[M − H\]^-^287.9988287.9987**76**C~17~H~14~NO~3~ \[M − H\]^-^280.0979280.0974**77**C~15~H~11~FNO \[M − H\]^-^240.0830240.0829**78**C~16~H~11~N~2~O \[M − H\]^-^247.0877247.0876**79**C~17~H~13~N~2~O \[M − H\]^-^261.1033261.1032**80**C~16~H~14~NO~2~ \[M − H\]^-^252.1030252.1023**81**C~15~H~12~NO \[M − H\]^-^222.0924222.0923**82**C~15~H~13~N~2~O~2~ \[M + H\]^+^253.0972253.0974**83**C~16~H~15~N~2~O~3~ \[M + H\]^+^283.1077283.1080**84**C~15~H~11~N~2~O~3~ \[M − H\]^-^267.0775267.0773**85**C~15~H~11~N~2~O~3~ \[M − H\]^-^267.0775267.0770**86**C~15~H~10~BrN~2~O~3~ \[M − H\]^-^344.9880344.9878**87**C~15~H~10~Cl~2~NO \[M − H\]^-^290.0145290.0141**88**C~14~H~10~NO~3~ \[M − H\]^-^240.0666240.0662**89**C~15~H~12~NO~4~ \[M − H\]^-^270.0772270.0769**90**C~15~H~12~NO~4~ \[M − H\]^-^270.0772270.0771**91**C~15~H~9~N~2~O~3~ \[M − H\]^-^265.0619265.0617**92**C~16~H~12~NO~5~ \[M − H\]^-^298.0721298.0717**93**C~16~H~12~NO~5~ \[M − H\]^-^298.0721298.0719**94**C~15~H~9~N~2~O~4~ \[M − H\]^-^281.0568281.0571**95**C~13~H~8~NO~4~ \[M − H\]^-^242.0459242.0454

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. HPLC analysis {#sec2.1}
------------------

### 2.1.1. Sample preparation and HPLC analysis {#sec2.1.1}

Approximately 0.1 mg of derivatives were dissolved in 1 mL of HPLC grade acetonitrile. 20 μL of supernatant was manually loaded onto the sample loop. The analysis was carried out on Agilent 1100 series and 1260 infinity system consisting of G1322A degasser, G1311A quat pump and G1365B multi-wavelength detector (MWD). The chromatographic parameters were set as follows:Mobile phase: Mobile phase A: MeCN, Mobile phase B: H~2~ODetector: MWD at 254 nmColumn: Agilent ZORBAX Eclipse Plus C18 (4.6 × 100 mm, 5 μm)Flow rate: 1.000 mL/minGradient programme:For compound **29, 60, 76, 87, 88**t/minMobile phase AMobile phase B030%70%240%60%350%50%980%20%1490%10%15100%0%16.580%20%1760%40%2030%70%For compound **34, 62, 94**t/minMobile phase AMobile phase B010%90%830%70%1450%50%24100%0%2580%20%2740%60%2810%90%For the remaining compounds **except** compounds **22, 24, 27, 33, 74**t/minMobile phase AMobile phase B030%70%240%60%350%50%13100%0%16.530%70%

### 2.1.2. Data processing {#sec2.1.2}

The automated integration software ChemStation for LC systems B.03.02 \[341\] was used to acquire the *area under the curve* (mAU). The obtained spectra were then exported as images.

2.2. qNMR analysis {#sec2.2}
------------------

### 2.2.1. Sample preparation and qNMR analysis {#sec2.2.1}

Samples were weighed into 5 mm standard NMR tubes using OHAUS® analytical plus balance, followed by addition of 500 μL of DMSO-d~6~ and indicated volume of internal reference 1,3,5-trioxane (99.66% pure, 9.98 mg/mL in DMSO-d~6~) purchased from Dieckmann (Hong Kong) Chemical Industry co., LTD. qNMR analysis were carried out *via* Bruker ultrashield™ NMR spectrometer 600 MHz. NMR instrument controlled parameters were adjusted as follows \[[@bib5]\]:Sample Temperature: 25 °C (298 K, regulated ± 0.1 K)Data Points (acquired): 64 KZero-Filling (SI or FN): to 256 KDummy Scans: 4Relaxation delay (D1): 60 sScans (NS or NT): 16

### 2.2.2. Data processing {#sec2.2.2}

The software Bruker topspin 3.2 was used to acquire the integrals of the signals of sample and internal reference. The normalized integrals values per proton equivalent by dividing each integral by the corresponding number of protons were calculated, so as the integral of the analyte (***Int***~***t***~ and ***Int***~***IC***~) as the average of all normalized integrals. The total number of protons (***n***~***t***~ and ***n***~***IC***~) was set to one \[[@bib5]\]. Purities was then calculated according to the equation as below:$$P\ \left\lbrack \% \right\rbrack = \ \frac{n_{IC} \ast Int_{t} \ast MW_{t} \ast m_{IC}}{n_{t} \ast Int_{IC} \ast MW_{IC} \ast m_{s}} \ast P_{IC}$$where: ***P*** = purity of tested compound***m***~***IC***~ = weight of the internal calibrant (IC)***m***~***s***~ = weight of the sample***Int***~***IC***~ = integral of the IC resonance signal being used for quantification***Int***~***t***~ = integral of the target analyte (t) resonance signal being used for quantification***n***~***IC***~ = number of protons that give rise to ***Int***~***IC***~***n***~***t***~ = number of protons of the target analyte that give rise to ***Int***~***t***~***MW***~***IC***~ = molecular weight of the internal calibrant***MW***~***t***~ = molecular weight of the target analyte***P***~***IC***~ = purity of the internal calibrant, as percent value

2.3. HRMS analysis for all compounds {#sec2.3}
------------------------------------

### 2.3.1. Sample preparation and HRMS analysis {#sec2.3.1}

Approximately 0.1 mg of derivatives were dissolved in 1 mL of HPLC grade acetonitrile. After sonication and filtration *via* 0.22 μm PTFE syringe filter, 10 μL of the upper layer was injected using an autosampler onto Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS spectrometer. The spectrometer was calibrated before each chromatographic run for optimal mass accuracy. The mobile phase gradient was 100% acetonitrile, at a flow rate of 0.5 ml/min. The mass spectra were acquired in positive- or negative-ion mode with source temperature at 300 °C. Ion spray voltage and fragmentor voltage were adjusted to 3.5 kV and 175 V, respectively. The range of mass detected was between 100 m/z and 1000 m/z.

### 2.3.2. Data processing {#sec2.3.2}

HRMS profiles were acquired and processed using MassHunter B.07 software. The obtained spectra were then exported as images.
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